Llewellyn W (2011). Anabolics. Molecular Nutrition LLC. pp. 180–182, 331–334. ISBN978-0-9828280-1-4. Archived from the original on 3 July 2022. Retrieved 3 January 2018.
Behre HM, Abshagen K, Oettel M, Hübler D, Nieschlag E (May 1999). "Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies". European Journal of Endocrinology. 140 (5): 414–419. CiteSeerX10.1.1.503.1752. doi:10.1530/eje.0.1400414. PMID10229906. S2CID22597244.
Täuber U, Schröder K, Düsterberg B, Matthes H (1986). "Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone". European Journal of Drug Metabolism and Pharmacokinetics. 11 (2): 145–149. doi:10.1007/BF03189840. PMID3770015. S2CID32305408.
Täuber U, Schröder K, Düsterberg B, Matthes H (April 1986). "Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone". European Journal of Drug Metabolism and Pharmacokinetics. 11 (2): 145–149. doi:10.1007/BF03189840. PMID3770015.
Behre HM, Nieschlag E, Nieschlag S (26 July 2012). "Testosterone preparations for clinical use in males". In Nieschlag E, Behre HM, Nieschlag S (eds.). Testosterone: Action, Deficiency, Substitution. Cambridge University Press. pp. 309–335. doi:10.1017/CBO9781139003353.016. ISBN978-1-107-01290-5.
Bagchus WM, Hust R, Maris F, Schnabel PG, Houwing NS (March 2003). "Important effect of food on the bioavailability of oral testosterone undecanoate". Pharmacotherapy. 23 (3): 319–325. doi:10.1592/phco.23.3.319.32104. PMID12627930. S2CID24440953.
Behre HM, Wang C, Handelsman DJ, Nieschlag E (1 January 2001). "Pharmacology of testosterone preparations". Testosterone: 405–444. doi:10.1017/CBO9780511545221.015.
Lachance S, Dhingra O, Bernstein J, Gagnon S, Savard C, Pelletier N, et al. (November 2015). "Importance of measuring testosterone in enzyme-inhibited plasma for oral testosterone undecanoate androgen replacement therapy clinical trials". Future Science OA. 1 (4): FSO55. doi:10.4155/fso.15.55. PMID28031910.
Behre HM, Abshagen K, Oettel M, Hübler D, Nieschlag E (May 1999). "Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies". European Journal of Endocrinology. 140 (5): 414–419. CiteSeerX10.1.1.503.1752. doi:10.1530/eje.0.1400414. PMID10229906. S2CID22597244.
Täuber U, Schröder K, Düsterberg B, Matthes H (1986). "Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone". European Journal of Drug Metabolism and Pharmacokinetics. 11 (2): 145–149. doi:10.1007/BF03189840. PMID3770015. S2CID32305408.
Täuber U, Schröder K, Düsterberg B, Matthes H (April 1986). "Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone". European Journal of Drug Metabolism and Pharmacokinetics. 11 (2): 145–149. doi:10.1007/BF03189840. PMID3770015.
Bagchus WM, Hust R, Maris F, Schnabel PG, Houwing NS (March 2003). "Important effect of food on the bioavailability of oral testosterone undecanoate". Pharmacotherapy. 23 (3): 319–325. doi:10.1592/phco.23.3.319.32104. PMID12627930. S2CID24440953.
Behre HM, Abshagen K, Oettel M, Hübler D, Nieschlag E (May 1999). "Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies". European Journal of Endocrinology. 140 (5): 414–419. CiteSeerX10.1.1.503.1752. doi:10.1530/eje.0.1400414. PMID10229906. S2CID22597244.
semanticscholar.org
api.semanticscholar.org
Behre HM, Abshagen K, Oettel M, Hübler D, Nieschlag E (May 1999). "Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies". European Journal of Endocrinology. 140 (5): 414–419. CiteSeerX10.1.1.503.1752. doi:10.1530/eje.0.1400414. PMID10229906. S2CID22597244.
Täuber U, Schröder K, Düsterberg B, Matthes H (1986). "Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone". European Journal of Drug Metabolism and Pharmacokinetics. 11 (2): 145–149. doi:10.1007/BF03189840. PMID3770015. S2CID32305408.
Bagchus WM, Hust R, Maris F, Schnabel PG, Houwing NS (March 2003). "Important effect of food on the bioavailability of oral testosterone undecanoate". Pharmacotherapy. 23 (3): 319–325. doi:10.1592/phco.23.3.319.32104. PMID12627930. S2CID24440953.
Llewellyn W (2011). Anabolics. Molecular Nutrition LLC. pp. 180–182, 331–334. ISBN978-0-9828280-1-4. Archived from the original on 3 July 2022. Retrieved 3 January 2018.